1. Home
  2. VSTS vs RCKT Comparison

VSTS vs RCKT Comparison

Compare VSTS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$7.59

Market Cap

572.2M

Sector

N/A

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.41

Market Cap

340.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
RCKT
Founded
1936
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
572.2M
340.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VSTS
RCKT
Price
$7.59
$3.41
Analyst Decision
Sell
Buy
Analyst Count
4
14
Target Price
$5.95
$29.12
AVG Volume (30 Days)
3.2M
2.3M
Earning Date
01-30-2026
11-06-2025
Dividend Yield
0.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,734,839,000.00
N/A
Revenue This Year
$1.47
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.98
$2.19
52 Week High
$16.68
$13.50

Technical Indicators

Market Signals
Indicator
VSTS
RCKT
Relative Strength Index (RSI) 75.53 52.07
Support Level $7.10 $3.30
Resistance Level $7.71 $3.65
Average True Range (ATR) 0.40 0.19
MACD 0.09 0.05
Stochastic Oscillator 95.44 66.22

Price Performance

Historical Comparison
VSTS
RCKT

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: